SOST and obesity due to melanocortin 4 receptor deficiency: Indeed, we found the highest blood sclerostin concentrations in patients with obesity, who are metabolically more compromised compared to underweight and normal-weight individuals, suggesting that the concomitant increase of plasma sclerostin with adiposity might be involved in the worsening of bone quality in subjects with obesity.